Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ)

CNY 13.15

(1.86%)

Revenue Summary of Chongqing Pharscin Pharmaceutical Co., Ltd.

  • Chongqing Pharscin Pharmaceutical Co., Ltd.'s latest annual revenue in 2023 was 691.54 Million CNY , down -11.93% from previous year.
  • Chongqing Pharscin Pharmaceutical Co., Ltd.'s latest quarterly revenue in 2024 Q3 was 196.37 Million CNY , up 5.88% from previous quarter.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. reported a annual revenue of 785.18 Million CNY in annual revenue 2022, down -7.2% from previous year.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. reported a annual revenue of 846.14 Million CNY in annual revenue 2021, down -4.12% from previous year.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. reported a quarterly revenue of 228.39 Million CNY for 2024 Q1, up 29.56% from previous quarter.
  • Chongqing Pharscin Pharmaceutical Co., Ltd. reported a quarterly revenue of 185.46 Million CNY for 2024 Q2, down -18.8% from previous quarter.

Annual Revenue Chart of Chongqing Pharscin Pharmaceutical Co., Ltd. (2023 - 2013)

Created with Highcharts 11.1.0YearsRevenue20132014201520162017201820192020202120222023200000000 CNY400000000 CNY600000000 CNY800000000 CNY1000000000 CNY

Historical Annual Revenue of Chongqing Pharscin Pharmaceutical Co., Ltd. (2023 - 2013)

Year Revenue Revenue Growth
2023 691.54 Million CNY -11.93%
2022 785.18 Million CNY -7.2%
2021 846.14 Million CNY -4.12%
2020 882.47 Million CNY 4.8%
2019 842.06 Million CNY 19.71%
2018 703.41 Million CNY 18.8%
2017 592.09 Million CNY 7.33%
2016 551.66 Million CNY 17.55%
2015 469.31 Million CNY 10.19%
2014 425.9 Million CNY 22.61%
2013 347.36 Million CNY 0.0%

Peer Revenue Comparison of Chongqing Pharscin Pharmaceutical Co., Ltd.

Name Revenue Revenue Difference
Tus-Pharmaceutical Group Co., Ltd. 395.92 Million CNY -74.666%
Jinling Pharmaceutical Company Limited 2.78 Billion CNY 75.176%
Jiuzhitang Co., Ltd. 2.91 Billion CNY 76.312%
Huapont Life Sciences Co., Ltd. 11.59 Billion CNY 94.036%
Zhejiang Hisoar Pharmaceutical Co., Ltd. 2.17 Billion CNY 68.159%
Shandong Wohua Pharmaceutical Co., Ltd. 894.31 Million CNY 22.673%
Jinhe Biotechnology CO., LTD. 2.17 Billion CNY 68.192%
Teyi Pharmaceutical Group Co.,Ltd 1.06 Billion CNY 35.201%
Kunming Longjin Pharmaceutical Co., Ltd. 86.62 Million CNY -698.341%
Beijing Aosaikang Pharmaceutical Co., Ltd. 1.44 Billion CNY 52.091%
Chengdu Kanghong Pharmaceutical Group Co., Ltd 3.95 Billion CNY 82.526%
Anhui Huangshan Capsule Co., Ltd. 458.36 Million CNY -50.87%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd 980.82 Million CNY 29.494%
Shanxi Zhendong Pharmaceutical Co.,Ltd 3.62 Billion CNY 80.928%
Beijing Science Sun Pharmaceutical Co., Ltd. 476.56 Million CNY -45.108%
Wuhan Hiteck Biological Pharma Co.,Ltd 602.28 Million CNY -14.82%
Dong-E-E-Jiao Co.,Ltd. 4.71 Billion CNY 85.334%
Zhejiang Garden Bio-chemical High-tech Co., Ltd. 1.09 Billion CNY 36.825%
Fujian Cosunter Pharmaceutical Co., Ltd. 422.71 Million CNY -63.596%
Jinghua Pharmaceutical Group Co., Ltd. 1.49 Billion CNY 53.602%
Hainan Haiyao Co., Ltd. 1.45 Billion CNY 52.544%
Dezhan Healthcare Company Limited 498.08 Million CNY -38.839%
Shenzhen Neptunus Bioengineering Co., Ltd. 36.41 Billion CNY 98.101%
Anhui Fengyuan Pharmaceutical Co., Ltd. 4.27 Billion CNY 83.825%
Livzon Pharmaceutical Group Inc. 12.27 Billion CNY 94.368%
Jilin Aodong Pharmaceutical Group Co., Ltd. 3.44 Billion CNY 79.95%
Changchun High-Tech Industries (Group) Inc. 14.46 Billion CNY 95.218%
Apeloa Pharmaceutical Co.,Ltd 11.47 Billion CNY 93.973%
Shandong Xinhua Pharmaceutical Company Limited 8 Billion CNY 91.365%
PKU HealthCare Corp.,Ltd. 2.19 Billion CNY 68.477%
Chengdu Huasun Technology Group Inc., Ltd. 1 Billion CNY 31.078%
Zhejiang Jingxin Pharmaceutical Co., Ltd. 3.95 Billion CNY 82.502%
Hengkang Medical Group Co., Ltd. 3.59 Billion CNY 80.74%
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 2.61 Billion CNY 73.51%
Qianjiang Yongan Pharmaceutical Co., Ltd. 962.8 Million CNY 28.174%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 5.42 Billion CNY 87.245%
LanZhou Foci Pharmaceutical Co.,Ltd. 1.16 Billion CNY 40.545%
Zhuhai Rundu Pharmaceutical Co., Ltd. 1.29 Billion CNY 46.47%
Huaren Pharmaceutical Co., Ltd. 1.63 Billion CNY 57.736%
Tianjin Ringpu Bio-Technology Co.,Ltd. 2.24 Billion CNY 69.251%
Fuan Pharmaceutical (Group) Co., Ltd. 2.64 Billion CNY 73.882%
Hybio Pharmaceutical Co., Ltd. 431.38 Million CNY -60.308%
Baotou Dongbao Bio-Tech Co.,Ltd 974.51 Million CNY 29.037%
Hunan Er-Kang Pharmaceutical Co., Ltd 1.76 Billion CNY 60.912%
Changjiang Pharmaceutical Group Co., Ltd. 1.19 Billion CNY 42.254%
Zhejiang Xinguang Pharmaceutical Co., Ltd. 270.39 Million CNY -155.748%
Hainan Poly Pharm. Co., Ltd 1.3 Billion CNY 46.987%
Jiangxi Synergy Pharmaceutical Co., Ltd. 722.13 Million CNY 4.237%
Zhejiang Tianyu Pharmaceutical Co., Ltd. 2.52 Billion CNY 72.637%
PharmaBlock Sciences (Nanjing), Inc. 1.72 Billion CNY 59.915%
Guangdong Lifestrong Pharmacy Co., Ltd. 292.39 Million CNY -136.508%
Betta Pharmaceuticals Co., Ltd. 2.45 Billion CNY 71.845%
Tibet AIM Pharm. Inc. 667.03 Million CNY -3.674%
Shenzhen Kangtai Biological Products Co., Ltd. 3.47 Billion CNY 80.113%
Shandong Shanda Wit Science and Technology Co., Ltd. 2.48 Billion CNY 72.162%
Pacific Shuanglin Bio-pharmacy Co., LTD 2.32 Billion CNY 70.304%
Zhejiang AngLiKang Pharmaceutical CO.,LTD. 1.62 Billion CNY 57.466%
Xiamen Kingdomway Group Company 3.1 Billion CNY 77.711%
ShanXi C&Y Pharmaceutical Group Co., Ltd. 799.3 Million CNY 13.482%
Walvax Biotechnology Co., Ltd. 4.11 Billion CNY 83.19%
Sunflower Pharmaceutical Group Co.,Ltd 5.63 Billion CNY 87.721%
Harbin Gloria Pharmaceuticals Co., Ltd 2.58 Billion CNY 73.299%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. 24.73 Billion CNY 97.205%
Hunan Hansen Pharmaceutical Co., Ltd. 955.53 Million CNY 27.627%
Changzhou Qianhong Biopharma CO.,LTD 1.79 Billion CNY 61.45%
Shenzhen Weiguang Biological Products Co., Ltd. 1.04 Billion CNY 34.045%
Honz Pharmaceutical Co., Ltd. 739.56 Million CNY 6.494%
Northeast Pharmaceutical Group Co., Ltd. 8.16 Billion CNY 91.527%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd 1.46 Billion CNY 52.721%
Guizhou Xinbang Pharmaceutical Co., Ltd. 6.46 Billion CNY 89.296%
Tianjin Lisheng Pharmaceutical Co.,Ltd. 1.13 Billion CNY 38.81%
Zhejiang Yatai Pharmaceutical Co., Ltd. 420.64 Million CNY -64.401%
Zhejiang NHU Company Ltd. 15.11 Billion CNY 95.425%
ApicHope Pharmaceutical Co., Ltd 2.5 Billion CNY 72.376%
Shanghai Kaibao Pharmaceutical CO.,Ltd 1.59 Billion CNY 56.617%
Beijing SL Pharmaceutical Co., Ltd. 1.01 Billion CNY 32.092%
Yunnan Baiyao Group Co.,Ltd 38.9 Billion CNY 98.222%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD 1.08 Billion CNY 35.971%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. 839.25 Million CNY 17.601%
Huadong Medicine Co., Ltd 40.39 Billion CNY 98.288%
Jiangsu Nhwa Pharmaceutical Co., LTD 4.97 Billion CNY 86.095%
Harbin Medisan Pharmaceutical Co., Ltd. 1.18 Billion CNY 41.73%
Tianjin Chase Sun Pharmaceutical Co.,Ltd 6.12 Billion CNY 88.714%
Beijing Beilu Pharmaceutical Co., Ltd 890.71 Million CNY 22.361%
Nanjing Hicin Pharmaceutical Co., Ltd. 517.83 Million CNY -33.546%
Renhe Pharmacy Co., Ltd. 5.03 Billion CNY 86.257%
Zhejiang Xianju Pharmaceutical Co.,Ltd. 4.12 Billion CNY 83.229%
Luoxin Pharmaceuticals Group Stock Co., Ltd. 2.34 Billion CNY 70.48%
Guizhou Bailing Group Pharmaceutical Co., Ltd. 4.26 Billion CNY 83.778%